US tariffs jeopardize medicine supply chains | Science

In April, the Trump administration announced sweeping tariffs on key trade partners, and it is poised to include pharmaceuticals next (1). Tariffs increase input costs for domestic drug manufacturers, particularly producers of generic medications, who operate on thin margins (2, 3). Moreover, because the US produces only a fraction of the generic medications that it needs (4…
Read More